Armin holds over 20 years of leadership experience from a variety of start-up and Fortune 500 companies as well as consulting engagements. He currently serves as CEO of Crown Bioscience, a leading global pre-clinical and translational contract research organization with a particular focus in oncology. He is also a Board Observer to diagnostics company SeromYx and a Strategic Advisor for Life Sciences investment company KYTO.
Armin’s previous roles included leading the Asia Pacific and Greater China expansion strategy for CareDx, a pioneer in transplant diagnostics, as well as global product commercialization efforts for Wuxi NextCODE's data analysis and AI solutions. He has also held multiple leadership positions at Life Technologies and Thermo Fisher Scientific, as General Manager for a China-based joint venture with Da'An Diagnostics, as well as GM for Professional Services for the Genomics Business. Earlier in his career, Armin helped grow two start-up companies: Ingenuity Systems (acquired by Qiagen) and ForteBio (now part of Danaher). Armin studied Biochemistry in Germany and received his Ph.D. in Molecular Biology from Brown University.